Cited by 1,097Schizophrenia research and treatmentPsychometric Methodologies and TestingMental Health and Psychiatry

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Morosini, P.L., Magliano, L., Brambilla, L., Ugolini, S., Pioli, R.·2000·Acta Psychiatrica Scandinavica

DOI 10.1034/j.1600-0447.2000.101004323.x

Open this paper in CoChat — free account

Abstract

Morosini P‐L, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatr Scand 2000: 101:323–329. © Munksgaard 2000. Objective: Development of a scale to assess patients' social functioning, the Personal and Social Performance scale (PSP). Method: PSP has been developed through focus groups and reliability studies on the basis of the social functioning component of the DSM‐TV Social and Occupational Functioning Assessment Scale (SOFAS). The last reliability study was carried out by 39 workers with different professional roles on a sample of 61 psychiatric patients admitted to the rehabilitation unit. Each patient was rated independently on the scale by the two workers who knew them best. Results: The PSP is a 100–point single‐item rating scale, subdivided into 10 equal intervals. The ratings are based mainly on the assessment of patient's functioning in four main areas: 1) socially useful activities; 2) personal and social relationships; 3) self‐care; and 4) disturbing and aggressive behaviours. Operational criteria to rate the levels of disabilities have been defined for the above‐mentioned areas. Excellent inter‐rater reliability was also obtained in less educated workers. Conclusion: Compared to SOFAS, PSP has better face validity and psychometric properties. It was found to be an acceptable, quick and valid measure of patients' personal and social functioning.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0447.2000.101004323.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Diagnostic and Statistical Manual of Mental Disorders
Sciacca, F., Sharma, R., & Knipe, H. (2020) · Radiopaedia.org · doi:10.53347/rid-80880 · Cited by 2,395
Health Measurement Scales: A Practical Guide To Their Development And Use
Streiner, D. L., & Norman, G. R. (2003) · doi:10.1093/oso/9780198528470.001.0001 · Cited by 1,460
Revising axis V for DSM-IV: a review of measures of social functioning
Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1148 · Cited by 1,408
A quality of life interview for the chronically mentally ill
Lehman, A. F. (1988) · Evaluation and Program Planning · doi:10.1016/0149-7189(88)90033-x · Cited by 1,085
A Brief Mental Health Outcome Scale
Jones, S. H., Thornicroft, G., Coffey, M., & Dunn, G. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.5.654 · Cited by 1,019
Burden on the families of patients with schizophrenia: results of the BIOMED I study
Magliano, L., Fadden, G., Madianos, M. G., Caldas‐de‐Almeida, J. M., Held, T., Guarneri, M., Marasco, C., Tosini, P., & Maj, M. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050073 · Cited by 308
Self-citation
Dr. Goldman Replies
GOLDMAN, M. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1119-a · Cited by 285
Evidence for limited validity of the revised global assessment of functioning scale
Roy‐Byrne, P., Dagadakis, C. S., Unützer, J., & Ries, R. R. (1996) · Psychiatric Services · doi:10.1176/ps.47.8.864 · Cited by 106

Show all 12 references

Research works printed but not linked: 7

Morosini PL, 1988, Disabiliti sociale e carico familiare: studio di riproducibilità di un nuovo strumento di valutazione, Riv Speriment Fren, 112, 541
Morosini PL, 1991, Routine assessment tools in psychiatry: a questionnaire on family attitudes and burden, Ital J Psychiatr Behav Sci, 1, 95
Magliano L, 1993, Studio di riproducibilità di un' intervista semi‐strutturata per l'accertamento della disabilità sociale e del carico familiare (ADC), Riv Riabilitaz Psichiatr Psicosoc, 2, 49
Morosini PL, 1998, VADO — Valu tazione di Abilita, Definizione di Obiettivi
Moroslini PL, 1996, Prima validazione ed applicazione di uno strumento clinico‐epidemiologico per valutare gli esiti nella riabilitazione psichiatrica: DI. SA, Disabilita e Salute, Riv Speriment Fren, 5, 817
1992, Stata — Statistics/graphics/data management
1997, SPSS — Statistical Package for Social Sciences

Sorted by citations

Items 101–200 of 1,003

Effectiveness of Integrated Dual Diagnosis Treatment (IDDT) in Severe Mental Illness Outpatients with a Co-Occurring Substance Use Disorder
Kikkert, M., Goudriaan, A., de Waal, M., Peen, J., & Dekker, J. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.09.005 · Cited by 67
High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment
Grande, I., Sánchez‐Moreno, J., Solé, B., Jiménez, E., Torrent, C., Bonnín, C. D. M., Varo, C., Tabarés‐Seisdedos, R., Balanzá‐Martínez, V., Valls, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.012 · Cited by 66
Psychosocial functioning in first‐episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms
Stouten, L. H., Veling, W., Laan, W., van der Helm, M., & van der Gaag, M. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12210 · Cited by 66
Disability is already pronounced in young people with early stages of affective disorders: Data from an early intervention service
Hamilton, B. A., Naismith, S. L., Scott, E. M., Purcell, S., & Hickie, I. B. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.052 · Cited by 66
Patterns of admission to acute psychiatric in-patient facilities: a national survey in Italy
Preti, A., Rucci, P., Santone, G., Picardi, A., Miglio, R., Bracco, R., Norcio, B., & de Girolamo, G. (2008) · Psychological Medicine · doi:10.1017/s0033291708003607 · Cited by 66
Definition and Assessment of Disability in Mental Disorders under the Perspective of the International Classification of Functioning Disability and Health (ICF)
Linden, M. (2017) · Behavioral Sciences & the Law · doi:10.1002/bsl.2283 · Cited by 66
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
Najarian, D. M., Sanga, P., Wang, S., Lim, P., Singh, A., Robertson, M. J., Cohen, K., Schotte, A., Milz, R., Venkatasubramanian, R., et al. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab071 · Cited by 64
Violent Behavior in Acute Psychiatric Inpatient Facilities
Biancosino, B., Delmonte, S., Grassi, L. G., Santone, G., Preti, A., Miglio, R., & de Girolamo, G. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181bb0d6b · Cited by 68
Happiness in first-episode schizophrenia
Agid, O., McDonald, K., SIU, C. O., Tsoutsoulas, C., Wass, C., Zipursky, R. B., Foussias, G., & Remington, G. J. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.012 · Cited by 69
Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
Rauch, A.-S., & Fleischhacker, W. W. (2013) · CNS Drugs · doi:10.1007/s40263-013-0083-9 · Cited by 64
Long-term outcomes of trauma-focused treatment in psychosis
van den Berg, D. P. G., de Bont, P. A. J. M., van der Vleugel, B. M., de Roos, C., de Jongh, A., van Minnen, A., & van der Gaag, M. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2017.30 · Cited by 64
Measuring psychosocial outcomes in schizophrenia patients
Figueira, M., & Brissos, S. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283438119 · Cited by 86
Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment
Li, M., Chen, Z., Deng, W., He, Z., Wang, Q., Jiang, L., Ma, X., Wang, Y., Chua, S. E., Cheung, C. C. G., et al. (2011) · Psychological Medicine · doi:10.1017/s0033291711002157 · Cited by 64
No gender differences in social outcome in patients suffering from schizophrenia
Galderisi, S., Bucci, P., Üçok, A., & Peuskens, J. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.011 · Cited by 63
A longitudinal population-based study of carers of people with psychosis
Poon, A. W. C., Harvey, C. A., Mackinnon, A. J., & Joubert, L. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001195 · Cited by 63
An ecologically valid performance-based social functioning assessment battery for schizophrenia
Shi, C., He, Y., Cheung, E. F. C., Yu, X., & Chan, R. C. K. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.023 · Cited by 62
Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS®) in the Swedish COAST-study
Brain, C., Allerby, K., Sameby, B., Quinlan, P. S., Joas, E., Karilampi, U., Lindström, E., Eberhard, J., Burns, T., & Wærn, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.001 · Cited by 62
Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: A pilot investigation
Sachdev, P. S., Loo, C. K. A., Mitchell, P. B., & Malhi, G. S. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01382.x · Cited by 62
A place to live: Housing needs for people with psychotic disorders identified in the second Australian national survey of psychosis
Harvey, C. A., Killackey, E. J., Groves, A., & Herrman, H. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449301 · Cited by 61
Validation of the Italian version of Mini-ICF-APP, a short instrument for rating activity and participation restrictions in psychiatric disorders
Balestrieri, M., Isola, M., Bonn, R., Tam, T., Vio, A., Linden, M., & Maso, E. (2012) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796012000480 · Cited by 62
Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?
Glenthøj, L. B., Fagerlund, B., Hjorthøj, C. R., Jepsen, J. R. M., Bak, N. K., Kristensen, T. D., Wenneberg, C., Krakauer, K., Roberts, D. L., & Nordentoft, M. (2016) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2016.06.004 · Cited by 71
A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
Coppola, D., Liu, Y., Gopal, S., Remmerie, B., Samtani, M. N., Hough, D. W., Nuamah, I., Sulaiman, A., & Pandina, G. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-26 · Cited by 61
“Psychiatric evaluations included PANSS [19], PSP (Personal and Social Performance scale) [20], and CGI-S (Clinical Global Impression-Severity scale) [18], which were also periodically evaluated by qualified raters to monitor patient symptoms and to adjust concomitant psychiatric medications if required.”
Method
Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study
Üçok, A., Gorwood, P. A. P. M., & Karadayı, G. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.014 · Cited by 61
Childhood adversity and social functioning in psychosis: Exploring clinical and cognitive mediators
Palmier‐Claus, J. E., Berry, K., Darrell-Berry, H., Emsley, R., Parker, S., Drake, R., & Bucci, S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.004 · Cited by 63
Impairments of motor function among children with a familial risk of schizophrenia or bipolar disorder at 7 years old in Denmark: an observational cohort study
Burton, B. K., Thorup, A. A. E., Jepsen, J. R. M., Poulsen, G., Ellersgaard, D., Spang, K. S., Christiani, C. J., Hemager, N., Gantriis, D. L., Greve, A. N., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30103-7 · Cited by 65
Integrating clinical staging and phenomenological psychopathology to add depth, nuance, and utility to clinical phenotyping: a heuristic challenge
Nelson, B., McGorry, P. D., & Fernandez, A. V. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30316-3 · Cited by 61
The Danish High Risk and Resilience Study—VIA 11: Study Protocol for the First Follow-Up of the VIA 7 Cohort −522 Children Born to Parents With Schizophrenia Spectrum Disorders or Bipolar Disorder and Controls Being Re-examined for the First Time at Age 11
Thorup, A. A. E., Hemager, N., Søndergaard, A., Gregersen, M., Prøsch, Å. K., Krantz, M. F., Brandt, J. M., Carmichael, L., Melau, M., Ellersgaard, D., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00661 · Cited by 61
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics
Leucht, S., Rossum, I. W.-V., Heres, S., Arango, C., Fleischhacker, W. W., Glenthoj, B. Y., Leboyer, M., Leweke, F. M., Lewis, S. W., McGuire, P. K., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv019 · Cited by 60
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia
Rossi, A., Amore, M., Galderisi, S., Rocca, P., Bertolino, A., Aguglia, E., Amodeo, G., Bellomo, A., Bucci, P., Buzzanca, A., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.040 · Cited by 59
Metacognitive therapy in treatment-resistant psychosis: a multiple-baseline study.
Hutton, P., Morrison, A. P., Wardle, M., & Wells, A. (2014) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812001026 · Cited by 58
Assessing the efficacy of a modified assertive community-based treatment programme in a developing country
Botha, U. A., Koen, L., Joska, J. A., Hering, L., & Oosthuizen, P. P. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-73 · Cited by 58
Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
Correll, C. U., Skuban, A., Hobart, M., Ouyang, J., Weiller, E., Weiss, C., & Kane, J. M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.012 · Cited by 58
The Effects of Metacognition-Oriented Social Skills Training on Psychosocial Outcome in Schizophrenia-Spectrum Disorders: A Randomized Controlled Trial
Inchausti, F., García‐Poveda, N. V., Ballesteros-Prados, A., Sierra, J. O., Sánchez-Reales, S., Prado-Abril, J., Aldaz-Armendáriz, J. A., Mole, J. A., Dimaggio, G., Ottavi, P., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx168 · Cited by 58
A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania
Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics
Hargarter, L., Chérubin, P., Bergmans, P., Keim, S., Rancāns, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., & Schreiner, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.11.006 · Cited by 57
Gender Differences in Remission and Recovery of Schizophrenic and Schizoaffective Patients: Preliminary Results of a Prospective Cohort Study
Carpiniello, B., Pinna, F., Tusconi, M., Zaccheddu, E., & Fatteri, F. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/576369 · Cited by 57
A community-based peer support service for persons with severe mental illness in China
Fan, Y., Ma, N., Ma, L., Xu, W., Lamberti, J. S., & Caine, E. D. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1763-2 · Cited by 57
Childhood adversity and clinical and psychosocial outcomes in psychosis
Turner, S. E., Harvey, C. A., Hayes, L., Castle, D. J., Galletly, C. A., Sweeney, S., Shah, S., Keogh, L. A., & Spittal, M. J. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000684 · Cited by 58
Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial
Bucci, S., Barrowclough, C., Ainsworth, J. D., Morris, R., Berry, K., Machin, M., Emsley, R., Lewis, S. W., Edge, D., Buchan, I. E., et al. (2015) · Trials · doi:10.1186/s13063-015-0943-3 · Cited by 56
The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy
Bischof, M., Obermann, C., Hartmann-Riemer, M. N., Hager, O. M., Kirschner, M., Kluge, A., Strauss, G. P., & Kaiser, S. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1118-9 · Cited by 56
Longitudinal predictors of subjective recovery in psychosis
Law, H., Shryane, N., Bentall, R. P., & Morrison, A. P. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.158428 · Cited by 55
Use of psychiatric inpatient services by heavy users: Findings from a national survey in Italy
Morlino, M., Calento, A., Schiavone, V., Santone, G., Picardi, A., de Girolamo, G., & for the PROGRES-Acute group (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.11.005 · Cited by 55
Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
Cathomas, F., Guetter, K., Seifritz, E., Klaus, F., & Kaiser, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89335-9 · Cited by 55
A brief self‐administered psychological intervention to improve well‐being in patients with cancer: results from a feasibility study
Ramachandra, P., Booth, S., Pieters, T., Vrotsou, K., & Huppert, F. A. (2009) · Psycho-Oncology · doi:10.1002/pon.1516 · Cited by 54
Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?
Lindenmayer, J., Khan, A., McGurk, S. R., Kulsa, M. K. C., Ljuri, I., Ozog, V., Fregenti, S., Capodilupo, G., Buccellato, K. H., Thanju, A., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.012 · Cited by 54
Combining machine learning algorithms for prediction of antidepressant treatment response
Kautzky, A., Möller, H., Dold, M., Bartova, L., Seemüller, F., Laux, G., Riedel, M. J., Gäebel, W., & Kasper, S. F. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13250 · Cited by 53
Affect recognition as an independent social function determinant in schizophrenia
Pan, Y., Chen, S., Chen, W. J., & Liu, S.-K. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.11.003 · Cited by 53
Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders
Pinna, F., Deriu, L., Diana, E., Perra, V., Randaccio, R. P., Sanna, L., Tusconi, M., Carpiniello, B., & Cagliari Recovery Study Group (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0042-6 · Cited by 53
Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study
Bulgari, V., Iozzino, L., Ferrari, C., Picchioni, M., Candini, V., Francesco, A. D., Maggi, P., Segalini, B., & de Girolamo, G. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.016 · Cited by 53
No cognitive‐enhancing effect of GLP ‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia
Ishøy, P. L., Fagerlund, B., Broberg, B. V., Bak, N., Knop, F. K., Glenthoj, B. Y., & Ebdrup, B. H. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12711 · Cited by 54
The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia
Schaub, D., Brüne, M., Jaspen, E., Pajonk, F., Bierhoff, H., & Juckel, G. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0122-1 · Cited by 52
A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis
de Bont, P. A. J. M., van den Berg, D. P. G., van der Vleugel, B. M., de Roos, C., Mulder, C. L., Becker, E. S., de Jongh, A., van der Gaag, M., & van Minnen, A. (2013) · Trials · doi:10.1186/1745-6215-14-151 · Cited by 52
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
Forbes, A., Hobart, M., Ouyang, J., Shi, L., Pfister, S., & Hakala, M. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy002 · Cited by 52
Effects of high intensity interval training among overweight individuals with psychotic disorders: A randomized controlled trial
Romain, A. J., Fankam, C., Karelis, A. D., Letendre, E., Mikolajczak, G., Stip, É., & Abdel‐Baki, A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.021 · Cited by 52
Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia
García‐Portilla, M. P., Sáiz, P. A., Bousoño, M., Bascarán, T., Guzmán-Quilo, C., & Bobes, J. (2011) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(11)70003-6 · Cited by 51
Metacognitive training for young subjects ( MCT young version) in the early stages of psychosis: Is the duration of untreated psychosis a limiting factor?
Ussorio, D., Giusti, L., Wittekind, C. E., Bianchini, V., Malavolta, M., Pollice, R., Casacchia, M., & Roncone, R. (2016) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12059 · Cited by 51
Development of the PSYCHS : Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Woods, S. W., Parker, S., Kerr, M., Walsh, B. C., Wijtenburg, S. A., Prunier, N., Núñez, Á., Buccilli, K., Mourgues, C., Brummitt, K., et al. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13457 · Cited by 62
Predictive factors of functional capacity and real-world functioning in patients with schizophrenia
Menéndez-Miranda, I., García‐Portilla, M. P., García-Álvarez, L., Arrojo, M., Sánchez, P., Sarramea, F., Gomar, J. J., Bobes-Bascarán, T., Sierra, P., Sáiz, P. A., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2014.12.011 · Cited by 50
Cognitive–behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China
Li, Z.-J., Guo, Z.-H., Wang, N., Xu, Z.-Y., Qu, Y., Wang, X.-Q., Sun, J., Yan, L.-Q., Ng, R. M. K., Turkington, D., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291714002992 · Cited by 49
Substance use in youth at risk for psychosis
Carney, R., Yung, A. R., Amminger, G. P., Bradshaw, T., Glozier, N., Hermens, D. F., Hickie, I. B., Killackey, E. J., McGorry, P. D., Pantelis, C., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.026 · Cited by 49
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
Canuso, C. M., Youssef, E. A., Bossie, C. A., Turkoz, I., Schreiner, A., & Simpson, G. M. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282fce651 · Cited by 48
Social cognition and metacognition in obsessive–compulsive disorder: an explorative pilot study
Mavrogiorgou, P., Bethge, M., Luksnat, S., Nalato, F., Juckel, G., & Brüne, M. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0669-6 · Cited by 48
Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study
Haro, J. M., Altamura, C. A., Corral, R. M., Elkis, H., Evans, J., Krebs, M., Zink, M., MALLA, A. K., Méndez, I., Bernasconi, C., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.005 · Cited by 48
Culturally adapted Family Intervention (CaFI) for African-Caribbean people diagnosed with schizophrenia and their families: a mixed-methods feasibility study of development, implementation and acceptability
Edge, D., Degnan, A., Cotterill, S., Berry, K., Baker, J. A., Drake, R., & Abel, K. M. (2018) · Health Services and Delivery Research · doi:10.3310/hsdr06320 · Cited by 51
Syntactic complexity of spoken language in the diagnosis of schizophrenia: A probabilistic Bayes network model
Silva, A., Limongi, R., Mackinley, M., Ford, S. D., Alonso-Sánchez, M. F., & Palaniyappan, L. K. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.06.011 · Cited by 48
Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia
Apiquián, R., Ulloa, R. E., Herrera-Estrella, M., Moreno-Gómez, A., Erosa, S., Contreras, V., & Nicolini, H. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.028 · Cited by 47
Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion
Citrome, L. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.531259 · Cited by 47
A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocol
Lutgens, D., Iyer, S. N., Joober, R., Brown, T. G., Norman, R. M. G., Latimer, E. A., Schmitz, N., Abdel‐Baki, A., Abadi, S., & MALLA, A. K. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0404-2 · Cited by 47
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
Meltzer, H. Y., Share, D. B., Jayathilake, K., Salomon, R. M., & Lee, M. A. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001205 · Cited by 47
Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-analysis
Devoe, D. J. A., Braun, A., Seredynski, T., & Addington, J. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000273 · Cited by 49
Changes in social functioning over the course of psychotic disorders–A meta-analysis
de Winter, L., Couwenbergh, C., van Weeghel, J., Hasson-Ohayon, I., Vermeulen, J. M., Mulder, C. L., Boonstra, N., Klaver, K. M., Oud, M., de Haan, L., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.010 · Cited by 46
The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients
Brissos, S., Palhavã, F., Marques, J. G., Mexia, S., Carmo, A. L., Carvalho, M., Dias, C., Franco, J. D., Mendes, R., Zuzarte, P., et al. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0412-6 · Cited by 46
Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia
Zhou, F., Xiang, Y., Wang, C., Dickerson, F., Au, R. W. C., Zhou, J.-J., Zhou, Y., Shum, D., Chiu, H. F. K., Man, D. W. K., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.12.001 · Cited by 46
The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial
Glenthøj, L. B., Fagerlund, B., Randers, L., Hjorthøj, C. R., Wenneberg, C., Krakauer, K., Vosgerau, A., Gluud, C. N., Medalia, A. A., Roberts, D. L., et al. (2015) · Trials · doi:10.1186/s13063-014-0542-8 · Cited by 47
Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment
Faden, J., & Citrome, L. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1543409 · Cited by 44
Internet gaming as a coping method among schizophrenic patients facing psychological distress
Chang, Y.-H., Chang, K., Hou, W., Lin, C., & Griffiths, M. D. (2020) · Journal of Behavioral Addictions · doi:10.1556/2006.2020.00081 · Cited by 46
Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?
Brissos, S., Balanzá‐Martínez, V., Dias, V. V., Carita, A. I., & Figueira, M. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0200-z · Cited by 46
Structured Walking and Chronic Institutionalized Schizophrenia Inmates: A pilot RCT Study on Quality of Life
Loh, S. Y., Abdullah, A., Bakar, A. K. A., Maniam, T., & Jaafar, N. R. N. (2015) · Global Journal of Health Science · doi:10.5539/gjhs.v8n1p238 · Cited by 45
Feasibility and acceptability of suicide prevention therapy on acute psychiatric wards: randomised controlled trial
Haddock, G., Pratt, D., Gooding, P. A., Peters, S., Emsley, R., Evans, E., KELLY, J. A., Huggett, C., Munro, A., Harris, K., et al. (2019) · BJPsych Open · doi:10.1192/bjo.2018.85 · Cited by 45
The human connectome project for disordered emotional states: Protocol and rationale for a research domain criteria study of brain connectivity in young adult anxiety and depression
Tozzi, L., Staveland, B. R., Holt-Gosselin, B., Chesnut, M., Chang, S. E., Choi, D., Shiner, M., Wu, H., Lerma‐Usabiaga, G., Sporns, O., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116715 · Cited by 48
Reliability and validity of the Personal and Social Performance scale in patients with schizophrenia
Nafees, B., de Jonge, P. V. H., Stull, D. E., Pascoe, K. C., Price, M. J., Clarke, A. Y., & Turkington, D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.013 · Cited by 45
Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo
Baandrup, L., Fagerlund, B., & Glenthoj, B. Y. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0711-8 · Cited by 45
The impact of insight on social functioning in patients with schizophrenia
Erol, A., Delibas, H., Bora, O., & Mete, L. (2015) · International Journal of Social Psychiatry · doi:10.1177/0020764014548287 · Cited by 44
Is Personal Recovery in Schizophrenia Predicted by Low Cognitive Insight?
Giusti, L., Ussorio, D., Tosone, A., Di Venanzio, C., Bianchini, V., Necozione, S., Casacchia, M., & Roncone, R. (2015) · Community Mental Health Journal · doi:10.1007/s10597-014-9767-y · Cited by 44
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study
Rossi, A., Galderisi, S., Rocca, P., Bertolino, A., Mucci, A., Rucci, P., Gibertoni, D., Aguglia, E., Amore, M., Andriola, I., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0710-9 · Cited by 44
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study
Blanchard, J. J., Bradshaw, K., Garcia, C. P., Nasrallah, H. A., Harvey, P. D., Casey, D. E., Csoboth, C. T., Hudson, J. I., Julian, L. J., Lentz, E. L., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.011 · Cited by 44
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort
Fond, G. B., Bulzacka, E., Boucékine, M., Schürhoff, F., Berna, F. S., Godin, O., Aouizerate, B., Capdevielle, D., Chéreau, I., d’Amato, T., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.005 · Cited by 44
Early Signs Monitoring to Prevent Relapse in Psychosis and Promote Well-Being, Engagement, and Recovery: Protocol for a Feasibility Cluster Randomized Controlled Trial Harnessing Mobile Phone Technology Blended With Peer Support
Gumley, A. I., Bradstreet, S., Ainsworth, J. D., Allan, S., Álvarez‐Jiménez, M., Beattie, L., Bell, I. H., Birchwood, M. J., Briggs, A. H., Bucci, S., et al. (2020) · JMIR Research Protocols · doi:10.2196/15058 · Cited by 41
Prediction and Prevention in the Clinical High-Risk for Psychosis Paradigm: A Review of the Current Status and Recommendations for Future Directions of Inquiry
Worthington, M., & Cannon, T. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.770774 · Cited by 47
Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression
Dean, O. M., Turner, A., Malhi, G. S., Ng, C. H., Cotton, S., Dodd, S., Sarris, J. J., Samuni, Y., Tanious, M., Dowling, N. L., et al. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1341 · Cited by 43
mHealth technology to assess, monitor and treat daily functioning difficulties in people with severe mental illness: A systematic review
Jameel, L., Valmaggia, L., Barnes, G., & Cella, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.033 · Cited by 43
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
Iasevoli, F., Razzino, E., Altavilla, B., Avagliano, C., Barone, A., Ciccarelli, M., D’Ambrosio, L., Matrone, M., Milandri, F., Francesco, D. N., et al. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13174 · Cited by 42
Validation of the Taiwanese Mandarin version of the Personal and Social Performance scale in a sample of 655 stable schizophrenic patients
Wu, B., Lin, C.-H. S., Tseng, H.-F., Liu, W.-M., Chen, W.-C., Huang, L.-S., Sun, H., Chiang, S., & Lee, S.-M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.036 · Cited by 42
Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis
Rosengard, R., Malla, A., Mustafa, S. S., Iyer, S., Joober, R., Bodnar, M., Lepage, M., & Shah, J. (2019) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2018.2552 · Cited by 37
Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Bighelli, I., Wallis, S., Reitmeir, C., Schwermann, F., Salahuddin, N. H., & Leucht, S. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01526-1 · Cited by 48
Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis
Stouten, L. H., Veling, W., Laan, W., van der Helm, M., & van der Gaag, M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.023 · Cited by 41
Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross‐sectional study
Mizuno, Y., Hofer, A., Frajo-Apor, B., Wartelsteiner, F., Kemmler, G., Pardeller, S., Suzuki, T., Mimura, M., Fleischhacker, W. W., & Uchida, H. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12838 · Cited by 48
Stigma, discrimination and medication adherence in schizophrenia: Results from the Swedish COAST study
Brain, C., Sameby, B., Allerby, K., Quinlan, P. S., Joas, E., Lindström, E., Burns, T., & Wærn, M. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.016 · Cited by 40
Pharmacological Management of Persistent Hostility and Aggression in Persons With Schizophrenia Spectrum Disorders: A Systematic Review
Victoroff, J., Coburn, K. L., Reeve, A., Sampson, S. M., & Shillcutt, S. D. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13110335 · Cited by 40
The Important Role of Motivation and Pleasure Deficits on Social Functioning in Patients With Schizophrenia: A Network Analysis
Hu, H., Lau, W. Y. S., Eugenia, P., Hung, K. S. Y., Chen, S.-Y., Cheng, K., Cheung, E. F. C., Lui, S. S. Y., & Chan, R. C. K. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac017 · Cited by 40

Authors: Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R.
Corresponding author: Morosini, P.L.
ORCID: Magliano, L.
Venue: Acta Psychiatrica Scandinavica
Publisher: Wiley
Published: 2000-04
Volume: 101
Issue: 4
Pages: 323-329
ISSN: 0001-690X (ISSN-L)
1600-0447
DOI: 10.1034/j.1600-0447.2000.101004323.x
OpenAlex: W4244847179
Cited by: 1,097
References: 12
Citations by year: 2026: 30 · 2025: 47 · 2024: 40 · 2023: 70 · 2022: 100 · 2021: 86 · 2020: 154 · 2019: 80 · 2018: 77 · 2017: 57 · 2016: 73 · 2015: 56 · 2014: 44 · 2013: 47 · 2012: 32
FWCI: 0.23
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 632 d)
Locations: Acta Psychiatrica Scandinavica (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: SOFA, occupational functioning, psychometric validation, reliability statistics, acceptability, DSM-IV, psychiatric assessment instruments

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks